Patents Assigned to Luminare Incorporated
  • Patent number: 10592637
    Abstract: Disclosed is a computer-implemented method of screening a patient for end organ damage due to infection. The method entails receiving patient data relating to an identified patient in a computing system including a processor and memory coupled to the processor, wherein the memory stores programmable instructions executable by the processor. The presence of Systematic Inflammatory Response Syndrome is determined and then the presence or absence of a high probability of end organ damage due to infection. Each of the determining steps includes receiving, on a graphical user interface, one or more user selections presented on the graphical user interface and executing programmable instructions based on received user selections.
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: March 17, 2020
    Assignee: Luminare Incorporated
    Inventors: Narasimheswara Sarma Velamuri, Marcus Joel Christian Persson Rydberg
  • Patent number: D918224
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: May 4, 2021
    Assignee: Luminare Incorporated
    Inventors: Narasimheswara Sarma Velamuri, Marcus Joel Christian Persson Rydberg
  • Patent number: D996464
    Type: Grant
    Filed: January 28, 2022
    Date of Patent: August 22, 2023
    Assignee: Luminare Incorporated
    Inventors: Narasimheswara Sarma Velamuri, Marcus Joel Christian Persson Rydberg